Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
   Core EBITDA Growth(%) 25.857.7265.570.03-4.21

What is the latest Core EBITDA Growth ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Core EBITDA Growth ratio of SYNCOM FORMULATIONS (INDIA) is 25.85 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202425.85
Mar20237.72
Mar202265.57
Mar20170.03
Mar2016-4.21

How is Core EBITDA Growth of SYNCOM FORMULATIONS (INDIA) Trending?

Years Core EBITDA Growth % Change
Mar2024 25.85
234.84
Mar2023 7.72
-88.23
Mar2022 65.57
218,466.67
Mar2017 0.03
Positive
Mar2016 -4.21 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare Core EBITDA Growth ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,696.7 Cr -0.7% -4.3% 16.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,917.0 Cr -1.2% -3.6% -8.6% Stock Analytics
DIVIS LABORATORIES ₹158,982.0 Cr -6.6% -12.4% 22.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,306.0 Cr 0.7% 9.1% 7.2% Stock Analytics
CIPLA ₹121,442.0 Cr 0.3% 1.2% -5.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,752.0 Cr 0.4% -2.8% -12.7% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-0.7%

-4.3%

16.6%

SENSEX

-0.5%

-3.1%

1.4%


You may also like the below Video Courses